FMII
BMY.RT

Farmers & Merchants Investments Inc’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,329
Closed -$5K – 882
2020
Q4 		$5K Hold
7,329
– – ﹤0.01% 773
2020
Q3 		$16K Hold
7,329
– – ﹤0.01% 471
2020
Q2 		$26K Buy
+7,329
New +$26.4K ﹤0.01% 388

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Farmers & Merchants Investments Inc's BMY.RT Position: Q1 2021 in Review

Farmers & Merchants Investments Inc sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 7,329 shares — an estimated $5K sold.

Farmers & Merchants Investments Inc first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $26K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Farmers & Merchants Investments Inc reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 7,329 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $5K.
  • Farmers & Merchants Investments Inc first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • Farmers & Merchants Investments Inc's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $26K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Farmers & Merchants Investments Inc's 13F filing for Q1 2021, filed 14 Apr 2021.